SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment remains highly divided as investors weigh rising bond yields and geopolitical tensions against persistent optimism surrounding AI-related growth and major index performance. Traders are actively debating whether recent volatility indicates a sustained reversal or if the market is primed for a continuation of its current uptrend through dip-buying activity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trading amid intense community debate over whether the current tech-driven rally is a sustainable market cycle or an overextended speculative bubble prone to a sudden reversal. Investors are actively scrutinizing the impact of rising bond yields, geopolitical tensions, and the upcoming earnings reports from AI-heavy semiconductor names, while sentiment remains sharply divided between those playing for continued 'V-shaped' recovery patterns and those anticipating a major correction.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is capturing significant community attention as investors monitor the progress of the Clarity Act and celebrate recent network performance upgrades like the Alpenglow testnet. Market sentiment is further bolstered by sustained whale accumulation and the anticipation of a potential breakout toward triple-digit price levels.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors react to reports that the U.S. government has cleared the path for sales of its advanced AI chips to major Chinese tech firms. The community is actively debating the stock's massive market cap valuation and speculative nature ahead of the upcoming earnings report, with sentiment split between those expecting continued momentum and those cautious of a potential pullback.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is experiencing extreme volatility as investors react to a cooling semiconductor sector and shifting trade dynamics, with community sentiment deeply divided between those buying the dip for long-term AI-driven growth and those anticipating a sharper structural correction. Market participants are actively debating the sustainability of the sector's parabolic rise, closely watching for signs that this volatility marks a healthy consolidation or the start of a broader, more significant downward trend.

Robo.ai, Inc. engages in the design and development of smart electric vehicles. It aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology. The company was founded in 2016 and is headquartered in Dubai, United Arab Emirates.

Robo.ai Inc. - Ordinary Shares - Class B

Robo.ai Inc.

Robo.ai Inc. ($AIIO) is experiencing massive volatility and high-volume momentum as the community debates whether the stock is undergoing a legitimate short squeeze fueled by new file-compression technology or if it is a classic pump-and-dump scheme. Investors are closely monitoring the company's borrow rates and lack of available shares to short, with many debating whether the stock will reach double-digit figures or face a significant retracement.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense volatility as investors debate whether the stock is undergoing a healthy consolidation or a significant top following an aggressive rally driven by AI-related memory demand. The community remains deeply divided, with bulls pointing to robust supply constraints and long-term contracts as reasons for future growth, while bears emphasize technical weakness and the cyclical nature of the semiconductor industry.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is seeing intense market activity following a strategic 100 million dollar investment from its founders and stronger-than-expected quarterly financial results. The community is heavily focused on the potential for a massive short squeeze, driven by high short interest and anticipation surrounding potential regulatory developments.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is trending due to significant momentum from receiving conditional approval for a U.S. national bank charter, fueling optimism about its future growth and competitive position. The community is actively discussing the company's strong earnings trajectory and record-breaking expansion, though some investors remain cautious about volatility, credit risks, and the stock's historical tendency to face post-earnings pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of +15.79% and +25.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

<ul class="summary-bullets"><li>Vascular surgeons Dr. Patrick Geraghty and Dr. Patrick Muck — who led the earlier study — will head the new trial.</li><li>Separately, the company also announced that it has initiated a voluntary recall in the U.S. for its CGuard Prime 135 cm carotid stent delivery system.</li><li>The company also withdrew its full-year 2026 revenue guidance.</li></ul>&nbsp;Shares of InspireMD (NSPR) jumped 30% after hours on Friday after the company announced that the U.S. Food and Drug Administration has approved its application to start the CGUARDIANS III pivotal study of the SwitchGuard Neuro-Protection System, overshadowing the pessimism around the firm dropping its 2026 financial guidance.The trial will test the safety and effectiveness of SwitchGuard when used with the company’s CGuard Prime carotid stent during transcarotid artery revascularization or TCAR procedures. The device reverses blood flow to catch debris and help prevent strokes in patients with carotid artery disease.Vascular surgeons Dr. Patrick Geraghty and Dr. Patrick Muck — who led the earlier study — will head the new trial.“This is an important step toward offering a complete TCAR solution,” said CEO Marvin Slosman. The company hopes to launch SwitchGuard in the U.S. in 2027 if approved.InspireMD already won FDA approval for its CGuard Prime stent in June 2025.<h2 class="st-heading-2">Recall And Dropped Guidance</h2>Separately, the company also announced that it has initiated a voluntary recall in the U.S. for its CGuard Prime 135 cm carotid stent delivery system.The company said the delivery system did not meet technical performance expectations during a controlled commercial launch for carotid artery stenting (CAS) procedures. The recall applies only to the delivery system and does not affect the CGuard stent implant itself.There are no safety concerns for patients who have already received the implanted stent. InspireMD is pausing U.S. sales of the 135 cm version while it makes design improvements. The company expects FDA approval for the original CGuard delivery system in the third quarter of 2026 and for the enhanced Prime version in the first half of 2027. As a result, it has withdrawn its full-year 2026 revenue guidance.“Management believes this is the most prudent step given the impact of the temporary discontinuation of commercial activity in the U.S. pending the anticipated FDA approval of its original CGuard stent delivery system in the third quarter of 2026,” the company said.More details will be provided at the company’s first quarter earnings on May 4, InspireMD added.<h2 class="st-heading-2">How Did NSPR Retail Traders React?</h2>On Stocktwits, retail sentiment around NSPR stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume remained at ‘normal’ levels.A Stocktwits user expressed skepticism about upcoming dilution.<stembedurl>https://www.stocktwits.com/Thespectator/message/652062806</stembedurl>Another user dismissed the application news as nothing more than regular updates from biotech companies.<stembedurl>https://www.stocktwits.com/vcaelum/message/652062730</stembedurl><a href="https://stocktwits.com/symbol/NSPR">NSPR stock</a> has fallen 56% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-uone-stock-rally-38-percent-today/cZQVLLCReeY">Why Did UONE Stock Rally 38% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of Beam Global rose premarket on Thursday. (Representative image: Getty Images)

NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance

The trial will test the safety and effectiveness of SwitchGuard when used with the company’s CGuard Prime carotid stent during transcarotid artery revascularization or TCAR procedures.

Equity

The trial will test the safety and effectiveness of SwitchGuard when used with the company’s CGuard Prime carotid stent during transcarotid artery revascularization or TCAR procedures.


InspireMD (NYSE:NSPR) Stock Price Up 3.5% - What's Next?

InspireMD (NYSE:NSPR) Stock Price Up 3.5% - Here's What Happened...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)

InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

InspireMD (NYSE:NSPR) Trading Down 6.7% - What's Next?

InspireMD (NYSE:NSPR) Shares Down 6.7% - Time to Sell...

InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of +36.36% and +14.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC

Ghisallo Capital Management LLC purchased a new position in InspireMD, Inc. (NYSE:NSPR - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...

Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR

Rosalind Advisors Inc. lifted its position in InspireMD, Inc. (NYSE:NSPR - Free Report) by 70.6% during the third quarter, according to the company in its most recent filing with the Securities...

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.

NSPR
InspireMD Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest NSPR News

NSPRInspireMD Inc